Improving treatment safety for patients with alcohol withdrawal syndrome in hospitals
Improving the Safety of Treatment for Hospitalized Patients with Alcohol Withdrawal Syndrome
['FUNDING_OTHER'] · UNIVERSITY OF WASHINGTON · NIH-10897328
This study is looking at how doctors decide between two medications to help patients going through Alcohol Withdrawal Syndrome in the hospital, aiming to find safer and better ways to treat this serious condition.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10897328 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the care of hospitalized patients experiencing Alcohol Withdrawal Syndrome (AWS), a condition that can be life-threatening without proper management. The study will explore how healthcare providers choose between two common medications, benzodiazepines and phenobarbital, for treating AWS, and assess the risks of adverse events associated with each treatment. By conducting interviews and analyzing treatment outcomes, the research seeks to identify safer and more effective management strategies for AWS in hospital settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized patients diagnosed with Alcohol Withdrawal Syndrome.
Not a fit: Patients who are not hospitalized or do not have a diagnosis of Alcohol Withdrawal Syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer treatment protocols for patients with alcohol withdrawal syndrome, reducing the risk of adverse events during hospitalization.
How similar studies have performed: While the treatment of Alcohol Withdrawal Syndrome has been studied, this research aims to rigorously compare the safety of two first-line therapies, which has not been extensively done before.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STEEL, TESSA LYNNE — UNIVERSITY OF WASHINGTON
- Study coordinator: STEEL, TESSA LYNNE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alcohol withdrawal syndrome